{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:18:47Z","timestamp":1707524327905},"reference-count":30,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,7,22]]},"DOI":"10.7759\/cureus.16558","type":"journal-article","created":{"date-parts":[[2021,7,22]],"date-time":"2021-07-22T14:07:26Z","timestamp":1626962846000},"source":"Crossref","is-referenced-by-count":0,"title":["Demographics, Biochemical Characteristics, and Phases of Chronic Hepatitis B Virus Infection: Retrospective Analysis From a Secondary Care Setup"],"prefix":"10.7759","author":[{"given":"Muhammad","family":"Ali Khan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad S","family":"Haider","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Baakh","family":"Nusrat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Syed Kumail","family":"Abbas Razvi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zunaira Z","family":"Shah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali M","family":"Shah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tahreem","family":"Khalid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farhan","family":"Haleem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1111\/liv.12409","article-title":"A brief history of hepatitis milestones","volume":"34","author":"Trepo C","year":"2014","unstructured":"Trepo C. A brief history of hepatitis milestones. Liver Int. 2014, 34:29-37. 10.1111\/liv.12409","journal-title":"Liver Int"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a024935","article-title":"Viral hepatitis B: clinical and epidemiological characteristics","volume":"4","author":"Burns GS","year":"2014","unstructured":"Burns GS, Thompson AJ. Viral hepatitis B: clinical and epidemiological characteristics. Cold Spring Harb Perspect Med. 2014, 4:a024935. 10.1101\/cshperspect.a024935","journal-title":"Cold Spring Harb Perspect Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1007\/978-981-13-9151-4_1","article-title":"Hepatitis B virus infection: overview","volume":"1179","author":"Li H","year":"2020","unstructured":"Li H, Yan L, Shi Y, Lv D, Shang J, Bai L, Tang H. Hepatitis B virus infection: overview. Adv Exp Med Biol. 2020, 1179:1-16. 10.1007\/978-981-13-9151-4_1","journal-title":"Adv Exp Med Biol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3390\/v11090850","article-title":"Hepatitis B virus (HBV) reactivation following pharmacological eradication of hepatitis C virus (HCV)","volume":"11","author":"Pisaturo M","year":"2019","unstructured":"Pisaturo M, Macera M, Alessio L, Cal\u00f2 F, Coppola N. Hepatitis B virus (HBV) reactivation following pharmacological eradication of hepatitis C virus (HCV). Viruses. 2019, 11:850. 10.3390\/v11090850","journal-title":"Viruses"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1007\/s12072-019-09988-7","article-title":"APASL HCV guidelines of virus-eradicated patients by DAA on how to monitor HCC occurrence and HBV reactivation","volume":"13","author":"Kanda T","year":"2019","unstructured":"Kanda T, Lau GK, Wei L, et al.. APASL HCV guidelines of virus-eradicated patients by DAA on how to monitor HCC occurrence and HBV reactivation. Hepatol Int. 2019, 13:649-61. 10.1007\/s12072-019-09988-7","journal-title":"Hepatol Int"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2017.07.046","article-title":"Hepatitis B vaccines: WHO position paper, July 2017 - recommendations","volume":"37","author":"World Health Organization","year":"2019","unstructured":"World Health Organization. Hepatitis B vaccines: WHO position paper, July 2017 - recommendations. Vaccine. 2019, 37:223-5. 10.1016\/j.vaccine.2017.07.046","journal-title":"Vaccine"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-1253(18)30198-5","article-title":"Global prevalence of hepatitis B virus infection and prevention of mother-to-child transmission","volume":"3","author":"Xu C","year":"2018","unstructured":"Xu C, Chen T. Global prevalence of hepatitis B virus infection and prevention of mother-to-child transmission. Lancet Gastroenterol Hepatol. 2018, 3:598-9. 10.1016\/S2468-1253(18)30198-5","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.2174\/1874357901812010033","article-title":"Determining the actual prevalence of hepatitis B in Khyber Pakhtunkhwa-Pakistan: a meta-analysis","volume":"12","author":"Khan NU","year":"2018","unstructured":"Khan NU, Zalan A, Petruzziello A, Ud Din I, Haq F, Hayat Y. Determining the actual prevalence of hepatitis B in Khyber Pakhtunkhwa-Pakistan: a meta-analysis. Open Virol J. 2018, 12:33-41. 10.2174\/1874357901812010033","journal-title":"Open Virol J"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.meegid.2018.06.013","article-title":"Molecular epidemiology of hepatitis delta and hepatitis B viruses circulating in two major provinces (East and North-West) of Pakistan","volume":"64","author":"Aftab M","year":"2018","unstructured":"Aftab M, Amin I, Idrees M, Ali A, Rafique S, Naz S. Molecular epidemiology of hepatitis delta and hepatitis B viruses circulating in two major provinces (East and North-West) of Pakistan. Infect Genet Evol. 2018, 64:65-9. 10.1016\/j.meegid.2018.06.013","journal-title":"Infect Genet Evol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1186\/1743-422X-8-102","article-title":"Hepatitis B virus in Pakistan: a systematic review of prevalence, risk factors, awareness status and genotypes","volume":"8","author":"Ali M","year":"2011","unstructured":"Ali M, Idrees M, Ali L, et al.. Hepatitis B virus in Pakistan: a systematic review of prevalence, risk factors, awareness status and genotypes. Virol J. 2011, 8:102. 10.1186\/1743-422X-8-102","journal-title":"Virol J"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-7-120","article-title":"Evaluation of immune response to Hepatitis B vaccine in health care workers at a tertiary care hospital in Pakistan: an observational prospective study","volume":"7","author":"Zeeshan M","year":"2007","unstructured":"Zeeshan M, Jabeen K, Ali AN, Ali AW, Farooqui SZ, Mehraj V, Zafar A. Evaluation of immune response to Hepatitis B vaccine in health care workers at a tertiary care hospital in Pakistan: an observational prospective study. BMC Infect Dis. 2007, 7:120. 10.1186\/1471-2334-7-120","journal-title":"BMC Infect Dis"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2017.03.021","article-title":"EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection","volume":"67","author":"European Association for the Study of the Liver","year":"2017","unstructured":"European Association for the Study of the Liver. EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection. J Hepatol. 2017, 67:370-98. 10.1016\/j.jhep.2017.03.021","journal-title":"J Hepatol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.3880","article-title":"Epidemiology, clinical characteristics, and management status of hepatitis B: a cross-sectional study in a tertiary care hospital at Karachi, Pakistan","volume":"11","author":"Butt N","year":"2019","unstructured":"Butt N, Ali Khan M, Haleem F, Butt S, Reema S, Qureshi T, Abbasi A. Epidemiology, clinical characteristics, and management status of hepatitis B: a cross-sectional study in a tertiary care hospital at Karachi, Pakistan. Cureus. 2019, 11:e3880. 10.7759\/cureus.3880","journal-title":"Cureus"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1186\/1471-230X-5-26","article-title":"Epidemiologic study of chronic hepatitis B virus infection in male volunteer blood donors in Karachi, Pakistan","volume":"5","author":"Akhtar S","year":"2005","unstructured":"Akhtar S, Younus M, Adil S, Hassan F, Jafri SH. Epidemiologic study of chronic hepatitis B virus infection in male volunteer blood donors in Karachi, Pakistan. BMC Gastroenterol. 2005, 5:26. 10.1186\/1471-230X-5-26","journal-title":"BMC Gastroenterol"},{"key":"ref15","article-title":"Risk factors and molecular epidemiology of HBV and HCV in internally displaced persons (IDPs) of North Waziristan Agency, Pakistan","volume":"68","author":"Khan A","year":"2018","unstructured":"Khan A, Qazi J. Risk factors and molecular epidemiology of HBV and HCV in internally displaced persons (IDPs) of North Waziristan Agency, Pakistan. J Pak Med Assoc. 2018, 68:165-9.","journal-title":"J Pak Med Assoc"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.meegid.2010.08.006","article-title":"Pattern and molecular epidemiology of Hepatitis B virus genotypes circulating in Pakistan","volume":"10","author":"Awan Z","year":"2010","unstructured":"Awan Z, Idrees M, Amin I, et al.. Pattern and molecular epidemiology of Hepatitis B virus genotypes circulating in Pakistan. Infect Genet Evol. 2010, 10:1242-6. 10.1016\/j.meegid.2010.08.006","journal-title":"Infect Genet Evol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1186\/1743-422X-8-420","article-title":"True prevalence of twin HDV-HBV infection in Pakistan: a molecular approach","volume":"8","author":"Khan AU","year":"2011","unstructured":"Khan AU, Waqar M, Akram M, et al.. True prevalence of twin HDV-HBV infection in Pakistan: a molecular approach. Virol J. 2011, 8:420. 10.1186\/1743-422X-8-420","journal-title":"Virol J"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1186\/s12978-020-0854-y","article-title":"Oligohydramnios: a prospective study of fetal, neonatal and maternal outcomes in low-middle income countries","volume":"17","author":"Figueroa L","year":"2020","unstructured":"Figueroa L, McClure EM, Swanson J, et al.. Oligohydramnios: a prospective study of fetal, neonatal and maternal outcomes in low-middle income countries. Reprod Health. 2020, 17:19. 10.1186\/s12978-020-0854-y","journal-title":"Reprod Health"},{"key":"ref19","article-title":"Frequency of hepatitis B and C in patients undergoing elective surgery","volume":"22","author":"Memon MR","year":"2010","unstructured":"Memon MR, Shaikh AA, Soomro AA, Arshad S, Shah QA. Frequency of hepatitis B and C in patients undergoing elective surgery. J Ayub Med Coll Abbottabad. 2010, 22:167-70.","journal-title":"J Ayub Med Coll Abbottabad"},{"key":"ref20","article-title":"Molecular and serological assessment of chronic HBV carriers and additional burden of applying updated guidelines in Pakistan","volume":"24","author":"Hussain AB","year":"2014","unstructured":"Hussain AB, Ahmed SA, Khan FA, Ghani E, Rathore MA, Ali N. Molecular and serological assessment of chronic HBV carriers and additional burden of applying updated guidelines in Pakistan. J Coll Physicians Surg Pak. 2014, 24:620-3.","journal-title":"J Coll Physicians Surg Pak"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.20661","article-title":"Basal core promoter, precore region mutations of HBV and their association with e antigen, genotype, and severity of liver disease in patients with chronic hepatitis B in India","volume":"78","author":"Chauhan R","year":"2006","unstructured":"Chauhan R, Kazim SN, Bhattacharjee J, Sakhuja P, Sarin SK. Basal core promoter, precore region mutations of HBV and their association with e antigen, genotype, and severity of liver disease in patients with chronic hepatitis B in India. J Med Virol. 2006, 78:1047-54. 10.1002\/jmv.20661","journal-title":"J Med Virol"},{"key":"ref22","article-title":"A study of genotypes, mutants and nucleotide sequence of hepatitis B virus in Pakistan: HBV genotypes in Pakistan","volume":"11","author":"Mumtaz K","year":"2011","unstructured":"Mumtaz K, Hamid S, Ahmed S, et al.. A study of genotypes, mutants and nucleotide sequence of hepatitis B virus in Pakistan: HBV genotypes in Pakistan. Hepat Mon. 2011, 11:14-8.","journal-title":"Hepat Mon"},{"key":"ref23","article-title":"The evidence of mother to child transmission of hepatitis B virus infection in Pakistan and the need for hepatitis B immunization policy change","volume":"64","author":"Qureshi H","year":"2014","unstructured":"Qureshi H, Javaid N, Alam SE, Bile KM. The evidence of mother to child transmission of hepatitis B virus infection in Pakistan and the need for hepatitis B immunization policy change. J Pak Med Assoc. 2014, 64:403-8.","journal-title":"J Pak Med Assoc"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.3760\/cma.j.issn.0254-6450.2016.06.010","article-title":"Effects related to HBeAg status and mode of delivery as well as the interactions on intrauterine transmission among HBsAg-positive mothers (Article in Chinese)","volume":"37","author":"Wen HX","year":"2016","unstructured":"Wen HX, Zhang F, Wang T, et al.. Effects related to HBeAg status and mode of delivery as well as the interactions on intrauterine transmission among HBsAg-positive mothers (Article in Chinese). Zhonghua Liu Xing Bing Xue Za Zhi. 2016, 37:791-5. 10.3760\/cma.j.issn.0254-6450.2016.06.010","journal-title":"Zhonghua Liu Xing Bing Xue Za Zhi"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2016.517","article-title":"ACG clinical guideline: evaluation of abnormal liver chemistries","volume":"112","author":"Kwo PY","year":"2017","unstructured":"Kwo PY, Cohen SM, Lim JK. ACG clinical guideline: evaluation of abnormal liver chemistries. Am J Gastroenterol. 2017, 112:18-35. 10.1038\/ajg.2016.517","journal-title":"Am J Gastroenterol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1111\/liv.12074","article-title":"Treatment of HBV related cirrhosis","volume":"33","author":"van B\u00f6mmel F","year":"2013","unstructured":"van B\u00f6mmel F, Berg T. Treatment of HBV related cirrhosis. Liver Int. 2013, 33:176-81. 10.1111\/liv.12074","journal-title":"Liver Int"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1089\/vim.2019.0048","article-title":"Characterization of hepatitis delta virus among pregnant women of Pakistan","volume":"32","author":"Aftab M","year":"2019","unstructured":"Aftab M, Naz S, Aftab B, et al.. Characterization of hepatitis delta virus among pregnant women of Pakistan. Viral Immunol. 2019, 32:335-40. 10.1089\/vim.2019.0048","journal-title":"Viral Immunol"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-1253(16)30107-8","article-title":"Tenofovir alafenamide versus tenofovir disoproxil fumarate for the treatment of patients with HBeAg-negative chronic hepatitis B virus infection: a randomised, double-blind, phase 3, non-inferiority trial","volume":"1","author":"Buti M","year":"2016","unstructured":"Buti M, Gane E, Seto WK, et al.. Tenofovir alafenamide versus tenofovir disoproxil fumarate for the treatment of patients with HBeAg-negative chronic hepatitis B virus infection: a randomised, double-blind, phase 3, non-inferiority trial. Lancet Gastroenterol Hepatol. 2016, 1:196-206. 10.1016\/S2468-1253(16)30107-8","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1007\/s00535-020-01698-4","article-title":"An expert review on the use of tenofovir alafenamide for the treatment of chronic hepatitis B virus infection in Asia","volume":"55","author":"Charlton MR","year":"2020","unstructured":"Charlton MR, Alam A, Shukla A, et al.. An expert review on the use of tenofovir alafenamide for the treatment of chronic hepatitis B virus infection in Asia. J Gastroenterol. 2020, 55:811-23. 10.1007\/s00535-020-01698-4","journal-title":"J Gastroenterol"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1089\/vim.2018.0022","article-title":"Predictors of therapeutic outcome to nucleotide reverse transcriptase inhibitor in hepatitis B patients","volume":"31","author":"Aziz M","year":"2018","unstructured":"Aziz M, Aziz H, Waheed Y, Gill ML. Predictors of therapeutic outcome to nucleotide reverse transcriptase inhibitor in hepatitis B patients. Viral Immunol. 2018, 31:632-8. 10.1089\/vim.2018.0022","journal-title":"Viral Immunol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/64849-demographics-biochemical-characteristics-and-phases-of-chronic-hepatitis-b-virus-infection-retrospective-analysis-from-a-secondary-care-setup","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:28:06Z","timestamp":1707506886000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/64849-demographics-biochemical-characteristics-and-phases-of-chronic-hepatitis-b-virus-infection-retrospective-analysis-from-a-secondary-care-setup"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,22]]},"references-count":30,"URL":"https:\/\/doi.org\/10.7759\/cureus.16558","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7,22]]}}}